Valid for Submission
D68.52 is a billable diagnosis code used to specify a medical diagnosis of prothrombin gene mutation. The code D68.52 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D68.52 might also be used to specify conditions or terms like heterozygous prothrombin g20210a mutation, homozygous prothrombin g20210a mutation or prothrombin g20210a mutation.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D68.52 are found in the index:
- - Prothrombin gene mutation - D68.52
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Heterozygous prothrombin G20210A mutation
- Homozygous prothrombin G20210A mutation
- Prothrombin G20210A mutation
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|814||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC||16||1.8907|
|815||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC||16||0.9925|
|816||RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC||16||0.6609|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D68.52 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D68.52 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.
Bleeding disorders can be the result of other diseases, such as severe liver disease or a lack of vitamin K. They can also be inherited. Hemophilia is an inherited bleeding disorder. Bleeding disorders can also be a side effect of medicines such as blood thinners.
Various blood tests can check for a bleeding disorder. You will also have a physical exam and history. Treatments depend on the cause. They may include medicines and transfusions of blood, platelets, or clotting factor.
[Learn More in MedlinePlus]
Prothrombin thrombophilia is an inherited disorder of blood clotting. Thrombophilia is an increased tendency to form abnormal blood clots in blood vessels. People who have prothrombin thrombophilia are at somewhat higher than average risk for a type of clot called a deep venous thrombosis, which typically occurs in the deep veins of the legs. Affected people also have an increased risk of developing a pulmonary embolism, which is a clot that travels through the bloodstream and lodges in the lungs. Most people with prothrombin thrombophilia never develop abnormal blood clots, however.
Some research suggests that prothrombin thrombophilia is associated with a somewhat increased risk of pregnancy loss (miscarriage) and may also increase the risk of other complications during pregnancy. These complications may include pregnancy-induced high blood pressure (preeclampsia), slow fetal growth, and early separation of the placenta from the uterine wall (placental abruption). It is important to note, however, that most women with prothrombin thrombophilia have normal pregnancies.
[Learn More in MedlinePlus]